CLTA Antikörper (C-Term)
-
- Target Alle CLTA Antikörper anzeigen
- CLTA (Clathrin, Light Chain A (CLTA))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CLTA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified
- Immunogen
- CLTA antibody was raised in rabbit using the C terminal of CLTA as the immunogen
- Top Product
- Discover our top product CLTA Primärantikörper
-
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
CLTA Blocking Peptide, catalog no. 33R-4345, is also available for use as a blocking control in assays to test for specificity of this CLTA antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- CLTA (Clathrin, Light Chain A (CLTA))
- Andere Bezeichnung
- CLTA (CLTA Produkte)
- Hintergrund
- Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Synonyms: Polyclonal CLTA antibody, Anti-CLTA antibody, clathrin, light chain, Lca antibody, LCA antibody.
- Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, EGFR Downregulation
-